Dr Lal Pathlabs, India’s largest diagnostic chain, posted a 19.3 per cent rise in profit after tax to Rs 98 crore for Q3FY25 ...

Dividend stocks 2025: Shree Cement, Coromandel International, and Dr Lal PathLabs share prices remained in focus on Wednesday ...

Quarterly Net Profit at Rs. 114.50 crore in December 2024 up 29.67% from Rs. 88.30 crore in December 2023. EBITDA stands at ...

Dr Lal PathLabs has approved a third interim dividend of ₹6 per equity share, which is 60% on a face value of ₹10 each, for ...

Shree Cement, Coromandel International, Dr Lal PathLabs share prices will remain in focus as will traded trade ex-date today.

JAIPUR: Cabinet Minister Dr Kirori Lal Meena has yet again stirred controversy in Rajasthan by claiming that his own party's ...

Rajasthan Cabinet Minister Dr. Kirodi Lal Meena, in a public meeting in Jaipur, had said that a CID team was deployed against ...

Dr Lal Pathlabs Ltd EBITDA grew 9.5% YoY to ₹154 crore, though margins contracted slightly to 25.8% from 26.1% last year ...

Dr Lal PathLabs reports a 19% rise in profit after tax for the third quarter ended December 31, 2024, reaching Rs 98 crore. Revenue also increased to Rs 597 crore.

India's Dr Lal Path Labs reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its shares 3% higher.

The diagnostics chain is currently expanding into tier-three and tier-four markets and is holding off on price increases to ...

Dividend stocks 2025: Shree Cement, Coromandel International, and Dr Lal PathLabs share prices remained in focus on Wednesday, February 5, as these stocks traded ex-date today. The record date for ...